Digital Health Drug Repository

The Digital Health Drug Repository (DHDR) represents the first foundational component of the province’s Comprehensive Drug Profile Strategy (CDPS). The DHDR is an electronic repository of dispensed drug and pharmacy service information that will expand on what has been available to date in the Drug Profile Viewer (DPV).

The DHDR will provide incrementally expanded access to records of dispensed drug events and pharmacy services to authorized health care providers. These currently include records relating to publicly funded drugs, monitored drugs and pharmacy services which are held by the Ministry of Health and Long-Term Care. Over time, the DHDR will expand further to include pharmacy records for drugs paid for directly by patients or by private insurance. Future enhancements to DHDR could include the addition of prescribed drug events in electronic medical record systems (EMRs) and hospital information systems (HIS).

Initially, the DHDR is being integrated with the connecting South West Ontario (cSWO) Regional Clinical Viewer, ClinicalConnect™ to further enhance the data and information currently available in the integrated electronic health record (EHR) in South West Ontario. The DHDR will be integrated with other regional clinical viewers in areas beyond South West Ontario, starting with the Greater Toronto Area region.

The Ministry of Health and Long-Term Care has posted a notice regarding the provision of access to information about publicly funded drugs, monitored drugs and pharmacy services, which can be found at ontario.ca/mydruginfo.

More information about the information accessible by authorized health care providers through DHDR can be found here.

Benefits

Patient Benefits

  • Enhanced patient experience with the health care system since care will be provided by better informed health care providers

  • Improved patient-centered care by providing authorized health care providers secure electronic access to a patient’s drug and pharmacy service information and allowing them more time for diagnosis, treating and communicating with the patient

  • Improved patient outcomes and decreased risk of adverse drug events

Clinician Benefits

  • Access to clinically relevant drug and pharmacy service information enabling a patient’s Best Possible Medication History (BPMH)

  • Better integration of available drug data through existing EMRs, provincial digital health assets and other systems to quickly, securely and efficiently access data to enable the BPMH

  • Enhanced patient safety and continuity of care

  • Improved collaboration between health care providers through the sharing of patient clinical data